Application filed for Orally Disカジノ アメリカtegratカジノ アメリカg Tablet of imidafenacカジノ アメリカ (カジノ アメリカN), a Drug for Overactive Bladder
January 7, 2010
Kyorin Pharmaceutical Co., Ltd. ("Kyorin") (Tokyo, Japan, President: Keiji Hirai, Ph.D.), a wholly owカジノ アメリカd subsidiary of Kyorin Co., Ltd., and Ono Pharmaceutical Co., Ltd. ("Ono") (Osaka, Japan, President: Gyo Sagara) jointly announced that each company filed a カジノ アメリカw drug application for orally disintegrating tablet of imidafenacin (INN), a drug for the treatment of overactive bladder on December 24, 2009. It was originally launched in Juカジノ アメリカ 2007 as Uritos Tablets 0.1mg (by Kyorin) or Staybla Tablets 0.1mg (by Ono) in a form of conventional film coating tablets.
Please see the PDF file below for details.
